Clinical Trial Update: Evaluation of the Effectiveness of a New Generation of Myopia Control Lens on the Progression of Myopia in Children Aged 6 to 14 Years [NA]

View source ↗

Summary

Recruitment is ongoing for a new generation of myopia control lenses intended to slow myopia progression in children aged 6 to 14 years.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• New generation myopia control lens (trial product)

Snippet

Sponsor: Essilor International | Conditions: Myopia Progression | NA | Status: RECRUITING